scholarly article | Q13442814 |
P50 | author | Ileana L Piña | Q114291623 |
Paul A Heidenreich | Q37840942 | ||
Gregg C. Fonarow | Q38543909 | ||
David A. Bluemke | Q39818611 | ||
Javed Butler | Q63107356 | ||
Olga A Khavjou | Q87070675 | ||
Council on Clinical Cardiology | Q98732021 | ||
P2093 | author name string | Larry A Allen | |
Graham Nichol | |||
Thomas M Maddox | |||
Council on Cardiovascular Radiology and Intervention | |||
Nancy M Albert | |||
Marvin A Konstam | |||
John S Ikonomidis | |||
Michael Pham | |||
Council on Epidemiology and Prevention | |||
Justin G Trogdon | |||
American Heart Association Advocacy Coordinating Committee | |||
Stroke Council | |||
Council on Arteriosclerosis, Thrombosis and Vascular Biology | |||
P2860 | cites work | Palliative Care in the Treatment of Advanced Heart Failure | Q22306344 |
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...] | Q22306349 | ||
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE> | Q28204197 | ||
Improved treatment of hospitalized coronary artery disease patients with the get with the guidelines program | Q28221152 | ||
2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults | Q28239484 | ||
Heart disease and stroke statistics--2011 update: a report from the American Heart Association | Q29547236 | ||
Heart disease and stroke statistics--2012 update: a report from the American Heart Association | Q29547909 | ||
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines | Q29619614 | ||
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association | Q30080021 | ||
A reengineered hospital discharge program to decrease rehospitalization: a randomized trial | Q30228286 | ||
Cardiac performance measure compliance in outpatients: the American College of Cardiology and National Cardiovascular Data Registry's PINNACLE (Practice Innovation And Clinical Excellence) program | Q33629846 | ||
Long-term trends in Medicare payments in the last year of life | Q33725839 | ||
Interventions to reduce 30-day rehospitalization: a systematic review | Q34050414 | ||
The economic costs of illness: a replication and update | Q34313474 | ||
The care transitions intervention: results of a randomized controlled trial | Q34568833 | ||
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond | Q34615977 | ||
Contemporary treatment of heart failure: is there adequate evidence to support a unique strategy for African-Americans? Con position | Q34738535 | ||
Consensus statement: Palliative and supportive care in advanced heart failure | Q35800974 | ||
Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association | Q35806046 | ||
Heart failure clinics and outpatient management: review of the evidence and call for quality assurance | Q35879710 | ||
Clinical epidemiology of heart failure | Q35954269 | ||
Incidence and epidemiology of heart failure | Q36287940 | ||
Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology | Q36811824 | ||
Use of econometric models to estimate expenditure shares | Q36839690 | ||
National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008 | Q36944032 | ||
Acculturation and outcomes among patients with heart failure | Q37205787 | ||
Hospice use among patients with heart failure | Q37525157 | ||
Palliative care in congestive heart failure | Q37560224 | ||
Guided care and the cost of complex healthcare: a preliminary report. | Q37577888 | ||
Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007. | Q37799463 | ||
Potential impact of optimal implementation of evidence-based heart failure therapies on mortality | Q37884919 | ||
Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). | Q38371676 | ||
Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial | Q38375039 | ||
Associations between outpatient heart failure process-of-care measures and mortality | Q38492646 | ||
A randomized trial of a telephone care-management strategy | Q39835102 | ||
The care transitions intervention: translating from efficacy to effectiveness | Q39992432 | ||
Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Int | Q40106164 | ||
The Seattle Heart Failure Model: prediction of survival in heart failure | Q40343385 | ||
Evaluation of the transitional care model in chronic heart failure. | Q42783441 | ||
Discharge education improves clinical outcomes in patients with chronic heart failure | Q43589881 | ||
Hospital performance recognition with the Get With The Guidelines Program and mortality for acute myocardial infarction and heart failure | Q44402061 | ||
Symptom recognition in elders with heart failure. | Q45943079 | ||
The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report--2010. | Q45945360 | ||
Insulin resistance and risk of congestive heart failure | Q46609295 | ||
Effectiveness and cost of a transitional care program for heart failure: a prospective study with concurrent controls | Q46839283 | ||
Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras | Q47298864 | ||
Race, quality of care, and outcomes of elderly patients hospitalized with heart failure | Q47898142 | ||
The Medical Expenditure Panel Survey: a national health information resource. | Q50107889 | ||
A national study of the quantity and cost of informal caregiving for the elderly with stroke. | Q50697432 | ||
ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation: a report of the ACCF Heart Failure and Transplant Committ | Q51042627 | ||
Modifiable risk factors for incident heart failure in the coronary artery surgery study. | Q51596688 | ||
Estimating log models: to transform or not to transform? | Q52058429 | ||
AHA/ACCF 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Perfo | Q57072822 | ||
Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006 | Q57243464 | ||
Social Support and Self-care in Heart Failure | Q57315242 | ||
Compliance with non-pharmacological recommendations and outcome in heart failure patients | Q57315246 | ||
Care and Outcomes of Hispanic Patients Admitted With Heart Failure With Preserved or Reduced Ejection Fraction | Q57630429 | ||
Association of race/ethnicity with clinical risk factors, quality of care, and acute outcomes in patients hospitalized with heart failure | Q57630486 | ||
Implementing American Heart Association Pediatric and Adult Nutrition Guidelines | Q58080508 | ||
ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Gu | Q58975447 | ||
Advanced Heart Failure and Transplant Cardiology: A Subspecialty Is Born | Q59192104 | ||
ACC/AHA Clinical Performance Measures for Adults With Chronic Heart Failure | Q62023646 | ||
Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction | Q73856257 | ||
Clinical definition and epidemiology of advanced heart failure | Q74660324 | ||
Transitional care of older adults hospitalized with heart failure: a randomized, controlled trial | Q79932365 | ||
Posthospital medication discrepancies: prevalence and contributing factors | Q81203289 | ||
Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial | Q81636956 | ||
Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994 | Q82484608 | ||
ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical As | Q84352844 | ||
American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care | Q94435023 | ||
ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consort | Q95479891 | ||
P433 | issue | 3 | |
P921 | main subject | United States of America | Q30 |
heart failure | Q181754 | ||
P304 | page(s) | 606-619 | |
P577 | publication date | 2013-04-24 | |
P1433 | published in | Circulation: Heart Failure | Q2865806 |
P1476 | title | Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association | |
P478 | volume | 6 |
Q88360656 | 30-Day Episode Payments and Heart Failure Outcomes Among Medicare Beneficiaries |
Q38620927 | A Central Role for Monocyte-Platelet Interactions in Heart Failure |
Q89891714 | A Comparison of Hospitalized Patients With Heart Failure and Cancer Referred to Palliative Care |
Q47105229 | A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function |
Q90716625 | A Network Pharmacology Approach to Explore the Mechanisms of Qishen Granules in Heart Failure |
Q90224720 | A Randomized Trial of Video-based Education in Patients With Heart Failure: The Congestive Heart Failure Outreach Program of Education (COPE) |
Q36961651 | A Remote Medication Monitoring System for Chronic Heart Failure Patients to Reduce Readmissions: A Two-Arm Randomized Pilot Study. |
Q39336176 | A Review of Prognostic Tools in Heart Failure. |
Q91505253 | A Roadmap for Value-Based Payment Models Among Patients With Cirrhosis |
Q36296879 | A Robust e-Epidemiology Tool in Phenotyping Heart Failure with Differentiation for Preserved and Reduced Ejection Fraction: the Electronic Medical Records and Genomics (eMERGE) Network |
Q89293222 | A Systematic Review of Cardiovascular Disease in Sexual Minorities |
Q38626987 | A Systematic Review of mHealth-Based Heart Failure Interventions |
Q92512572 | A Systems-Based Analysis of the CardioMEMS HF Sensor for Chronic Heart Failure Management |
Q35672064 | A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. |
Q38781009 | A functional variant of the neuropeptide S receptor-1 gene modulates clinical outcomes and healthcare utilization in patients with systolic heart failure: results from the Interdisciplinary Network Heart Failure (INH) Study |
Q47564964 | A mixed methods study of symptom perception in patients with chronic heart failure |
Q55075632 | A mobile system for the improvement of heart failure management: Evaluation of a prototype. |
Q91433760 | A mouse model of heart failure exhibiting pulmonary edema and pleural effusion: Useful for testing new drugs |
Q37675569 | A new twist on an old idea: a two-dimensional speckle tracking assessment of cyclosporine as a therapeutic alternative for heart failure with preserved ejection fraction |
Q37730741 | A novel approach for measuring residential socioeconomic factors associated with cardiovascular and metabolic health |
Q92894318 | A novel noninvasive method for remote heart failure monitoring: the EuleriAn video Magnification apPLications In heart Failure studY (AMPLIFY) |
Q39890028 | A prospective, observational study to explore health disparities in patients with heart failure-ethnicity and financial status |
Q40929884 | A randomized study of remote monitoring and fluid monitoring for the management of patients with implanted cardiac arrhythmia devices |
Q28297096 | AAV-mediated gene therapy for heart failure: enhancing contractility and calcium handling |
Q89071693 | Ablation for Atrial Fibrillation in Heart Failure with Reduced Ejection Fraction |
Q57128494 | Ablation of a Single N-Glycosylation Site in Human FSTL 1 Induces Cardiomyocyte Proliferation and Cardiac Regeneration |
Q52656155 | Accelerometer-Measured Daily Activity Levels and Related Factors in Patients With Heart Failure. |
Q50231051 | Acetylation of VGLL4 Regulates Hippo-YAP Signaling and Postnatal Cardiac Growth. |
Q41104203 | Activation of the Amino Acid Response Pathway Blunts the Effects of Cardiac Stress |
Q35139964 | Acute decompensated heart failure update |
Q37408637 | Acute heart failure with preserved ejection fraction: unique patient characteristics and targets for therapy |
Q57911301 | Acute heart failure: lessons learned, roads ahead |
Q38674901 | Acute mechanical circulatory support for cardiogenic shock: the "door to support" time |
Q48387891 | Addressing the conundrum of multimorbidity in heart failure: Do we need a more strategic approach to improve health outcomes? |
Q40967753 | Adherence to a Mediterranean diet is associated with reduced risk of heart failure in men. |
Q64959122 | Adiponectin is valuable in the diagnosis of acute heart failure with renal insufficiency. |
Q38665321 | Adverse Remodeling and Reverse Remodeling After Myocardial Infarction |
Q46136583 | Aerobic fitness, muscular strength and obesity in relation to risk of heart failure. |
Q44143731 | Almanac 2013: heart failure |
Q89071699 | Ambulatory Intra Aortic Balloon Pump in Advanced Heart Failure |
Q38219915 | Amino acids and derivatives, a new treatment of chronic heart failure? |
Q47724995 | An Intervention to Improve Physical Function and Caregiver Perceptions in Family Caregivers of Persons With Heart Failure |
Q64245345 | An update on the CardioMEMS pulmonary artery pressure sensor |
Q90673843 | Anabolism to Catabolism: Serologic Clues to Nutritional Status in Heart Failure |
Q89307259 | Anemia in heart failure - from guidelines to controversies and challenges |
Q38982213 | Angiotensin-Neprilysin Inhibition as a Paradigm for All? |
Q64948831 | Assessing Knowledge Regarding Managing Congestive Health Failure Symptoms: Differences in Patient and Professional Scores. |
Q27012929 | Assessing the Quality and Comparative Effectiveness of Team-Based Care for Heart Failure: Who, What, Where, When, and How |
Q52985344 | Assessment of cardiac sympathetic innervation with (123)I-mIBG SPECT comes to life: need for standardization! |
Q92018520 | Association Between Spending and Survival of Chronic Heart Failure Across Veterans Affairs Medical Centers |
Q39689820 | Association between cardiac, renal, and hepatic biomarkers and outcomes in patients with acute heart failure |
Q90219054 | Association between long-term adherence to class-I recommended medications and risk for potentially preventable heart failure hospitalizations among younger adults |
Q97557924 | Association of Adherence to Weight Telemonitoring With Health Care Use and Death: A Secondary Analysis of a Randomized Clinical Trial |
Q37240444 | Association of Age at Menopause With Incident Heart Failure: A Prospective Cohort Study and Meta-Analysis |
Q40249444 | Association of Holter-Derived Heart Rate Variability Parameters With the Development of Congestive Heart Failure in the Cardiovascular Health Study |
Q89266872 | Association of the Affordable Care Act's Medicaid Expansion With Care Quality and Outcomes for Low-Income Patients Hospitalized With Heart Failure |
Q90332618 | Associations Between Long-Term Fine Particulate Matter Exposure and Mortality in Heart Failure Patients |
Q56975424 | Atorvastatin, but not pravastatin, inhibits cardiac Akt/mTOR signaling and disturbs mitochondrial ultrastructure in cardiac myocytes |
Q39008820 | Atrial fibrillation and cognitive function in patients with heart failure: a systematic review and meta-analysis. |
Q39888565 | Augmenting Surgery via Multi-scale Modeling and Translational Systems Biology in the Era of Precision Medicine: A Multidisciplinary Perspective |
Q47655019 | Automating Quality Measures for Heart Failure Using Natural Language Processing: A Descriptive Study in the Department of Veterans Affairs |
Q36165288 | Autonomic Regulation Therapy in Heart Failure |
Q90249372 | Baduanjin exercise for patients with ischemic heart failure on phase-II cardiac rehabilitation (BEAR trial): study protocol for a prospective randomized controlled trial |
Q37090685 | Barriers to Adoption of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure: A Mixed-Methods Study |
Q52709074 | Beneficial effects of adaptive servo-ventilation therapy on readmission and medical costs in patients with chronic heart failure. |
Q94337976 | Beta‐blockers for heart failure |
Q36351720 | Biological significance of miR-126 expression in atrial fibrillation and heart failure |
Q33870611 | Biomaterial-Free Three-Dimensional Bioprinting of Cardiac Tissue using Human Induced Pluripotent Stem Cell Derived Cardiomyocytes |
Q40379760 | Blood pressure changes in patients with chronic heart failure undergoing slow breathing training |
Q52682504 | Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure. |
Q40935755 | Broadcasting Not Properly: Using B-type Natriuretic Peptide Interval Likelihood Ratios and the Results of Other Emergency Department Tests to Diagnose Acute Heart Failure in Dyspneic Patients |
Q38979269 | Burden and Timing of Hospitalizations in Heart Failure: A Community Study |
Q98241459 | Burden of Cirrhosis on Patients and Caregivers |
Q36784206 | Burden of Systolic and Diastolic Left Ventricular Dysfunction Among Hispanics in the United States: Insights From the Echocardiographic Study of Latinos |
Q47701044 | Can Mindfulness Training Improve Medication Adherence? Integrative Review of the Current Evidence and Proposed Conceptual Model |
Q31159585 | Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions |
Q92155818 | Cardiac Inotropic Effect of Long-Term Administration of Oral Thymoquinone |
Q38939243 | Cardiac Myosin Activators in Systolic Heart Failure: More Friend than Foe? |
Q93055900 | Cardiac Myosin Binding Protein-C Phosphorylation Mitigates Age-Related Cardiac Dysfunction: Hope for Better Aging? |
Q88711515 | Cardiac Resynchronisation Therapy and Heart Failure: Persepctive from 5P Medicine |
Q37416037 | Cardiac STAT3 Deficiency Impairs Contractility and Metabolic Homeostasis in Hypertension |
Q62471522 | Cardiac ScoreCard: A diagnostic multivariate index assay system for predicting a spectrum of cardiovascular disease |
Q37371212 | Cardiac contractility modulation: a novel approach for the treatment of heart failure |
Q55025652 | Cardiac myosin activators for heart failure therapy: focus on omecamtiv mecarbil. |
Q41598736 | Cardiac troponin and outcome in decompensated heart failure with preserved ejection fraction |
Q47265220 | Cardiac-specific ablation of the E3 ubiquitin ligase Mdm2 leads to oxidative stress, broad mitochondrial deficiency and early death |
Q64107766 | CardioMems® device implantation reduces repeat hospitalizations in heart failure patients: A single center experience |
Q39258979 | Cardiomyocyte Ca2+ homeostasis as a therapeutic target in heart failure with reduced and preserved ejection fraction. |
Q64229554 | Cardiomyocyte SMAD4-Dependent TGF-β Signaling is Essential to Maintain Adult Heart Homeostasis |
Q61659889 | Cardionephrology: Proposal for a Futuristic Educational Approach to a Contemporary Need |
Q91698768 | Cardiorespiratory fitness, body mass index and heart failure incidence |
Q40365259 | Cardiovascular Disease Risk Among Young Urban Women |
Q50098369 | Cardiovascular Medicine Amid Evolving Health Policy: Time to Train a Generation of Policy Leaders. |
Q33912880 | Cardiovascular magnetic resonance in an adult human population: serial observations from the multi-ethnic study of atherosclerosis. |
Q64906097 | Cardiovascular risk prediction in the elderly. |
Q42378575 | Cardiovascular risk reduction in African Americans: Current concepts and controversies |
Q35629821 | Care in the last year of life for community patients with heart failure |
Q37305320 | Caregiver Contribution to Heart Failure Self-Care (CACHS) |
Q55668722 | Caregiver Well-being and Patient Outcomes in Heart Failure: A Meta-analysis. |
Q38781161 | Caregiver determinants of patient clinical event risk in heart failure |
Q47599898 | Caregivers' perceptions of illness severity and end of life service utilization in advanced heart failure. |
Q87590979 | Carvedilol protects the infarcted heart by upregulating miR-133: first evidence that disease state affects β-adrenergic arrestin-biased signaling? |
Q47639049 | Cellular Therapeutics for Heart Failure: Focus on Mesenchymal Stem Cells. |
Q30357486 | Challenges and opportunities for translating medical microdevices: insights from the programmable bio-nano-chip. |
Q28085736 | Challenges in acute heart failure clinical management: optimizing care despite incomplete evidence and imperfect drugs |
Q57796885 | Changes in pulmonary artery pressure before and after left ventricular assist device implantation in patients utilizing remote haemodynamic monitoring |
Q43145398 | Chinese innovation in cardiovascular drug discovery |
Q33616957 | Chocolate Consumption and Risk of Heart Failure: A Meta-Analysis of Prospective Studies |
Q30359729 | Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure. |
Q88129484 | Circular noncoding RNAs as potential therapies and circulating biomarkers for cardiovascular diseases |
Q91638459 | Clinical characteristics of heart failure associated with functional dependence at admission in hospitalized elderly |
Q57176446 | Clinical correlates and heritability of cardiac mechanics: The HyperGEN study |
Q92858769 | Clinical efficacy, safety and tolerability of aliskiren monotherapy: a protocol for an umbrella review |
Q55282032 | Clinical implications of organ congestion in heart failure patients as assessed by ultrasonography. |
Q38588158 | Clinical management of patients with acute heart failure |
Q91604539 | Clinical outcomes and mortality in old and very old patients undergoing cardiac resynchronization therapy |
Q40485446 | Clinical presentation and outcome by age categories in acute heart failure: results from an international observational cohort |
Q38999245 | Coagulation Abnormalities in Heart Failure: Pathophysiology and Therapeutic Implications |
Q49022015 | Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure. |
Q39262364 | Combined Post- and Precapillary Pulmonary Hypertension in Patients With Heart Failure |
Q40000430 | Combining angiotensin II receptor 1 antagonism and neprilysin inhibition for the treatment of heart failure |
Q38717849 | Comorbidities in Heart Failure: Are There Gender Differences? |
Q38666884 | Comorbidity of atrial fibrillation and heart failure |
Q36021840 | Comparative effects of urocortins and stresscopin on cardiac myocyte contractility |
Q89912395 | Comparing inpatient costs of heart failure admissions for patients with reduced and preserved ejection fraction with or without type 2 diabetes |
Q99707623 | Comparison of learning needs priorities between healthcare providers and patients with heart failure |
Q38717846 | Complex Care Options for Patients With Advanced Heart Failure Approaching End of Life |
Q34635174 | Congestive heart failure adherence redesign trial: a pilot study |
Q26778120 | Considerations for initial therapy in the treatment of acute heart failure |
Q37041145 | Contemporary strategies in the diagnosis and management of heart failure |
Q41031667 | Corlanor (Ivabradine), First HCN Channel Blocker, FDA Approved for the Treatment of Patients with Heart Failure |
Q52604700 | Correcting Calcium Dysregulation in Chronic Heart Failure Using SERCA2a Gene Therapy. |
Q37723855 | Cost of heart failure management in Turkey: results of a Delphi Panel |
Q35357554 | Cost of informal caregiving for patients with heart failure |
Q36853325 | Cost-Effectiveness of Implantable Pulmonary Artery Pressure Monitoring in Chronic Heart Failure |
Q36956750 | Cost-Effectiveness of Ivabradine for Heart Failure in the United States |
Q38921111 | Cost-Effectiveness of Remote Cardiac Monitoring With the CardioMEMS Heart Failure System. |
Q88621944 | Cost-effectiveness of B-type natriuretic peptide-guided care in patients with heart failure: a systematic review |
Q101238372 | Cost-effectiveness of adding dapagliflozin to standard treatment for heart failure with reduced ejection fraction patients in China |
Q37344039 | Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece |
Q38612606 | Current Approach to Decongestive Therapy in Acute Heart Failure |
Q55182135 | Current Perspectives on Systemic Hypertension in Heart Failure with Preserved Ejection Fraction. |
Q89350823 | Current State of Pediatric Heart Failure |
Q36139763 | Current and projected burden of heart failure in the Australian adult population: a substantive but still ill-defined major health issue. |
Q50332202 | Current indications for transplantation: stratification of severe heart failure and shared decision-making. |
Q31172420 | DCDS: A Real-time Data Capture and Personalized Decision Support System for Heart Failure Patients in Skilled Nursing Facilities |
Q49794362 | Defining the molecular signatures of human right heart failure. |
Q38827917 | Defining the role of ultrafiltration therapy in acute heart failure: a systematic review and meta-analysis |
Q35864658 | Dementia severity and the longitudinal costs of informal care in the Cache County population |
Q38969053 | Depression increases the risk of mortality in patients with heart failure: A meta-analysis |
Q37742294 | Design and Usability of a Heart Failure mHealth System: A Pilot Study |
Q63284032 | Design and rationale of the B-lines lung ultrasound guided emergency department management of acute heart failure (BLUSHED-AHF) pilot trial |
Q46746456 | Design of a bilevel clinical trial targeting adherence in heart failure patients and their providers: The Congestive Heart Failure Adherence Redesign Trial (CHART). |
Q47148472 | Designing and Testing an End-of-Life Discussion Intervention for African American Patients With Heart Failure and Their Families |
Q34162294 | Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries |
Q37220202 | Detection and prognostic value of pulmonary congestion by lung ultrasound in ambulatory heart failure patients |
Q64109356 | Detection of Congestive Heart Failure Based on LSTM-Based Deep Network via Short-Term RR Intervals |
Q36304296 | Determinants of Heart Failure Self-Care Maintenance and Management in Patients and Caregivers: A Dyadic Analysis. |
Q52579369 | Determining 30-day readmission risk for heart failure patients: the Readmission After Heart Failure scale. |
Q38532870 | Development of a collaborative transitions-of-care program for heart failure patients |
Q28080130 | Diagnosing and managing acute heart failure in the emergency department |
Q64251843 | Diagnosing heart failure in centenarians |
Q58552891 | Diagnostic potential of circulating LncRNAs in human cardiovascular disease: a meta-analysis |
Q51769291 | Digoxin Benefit Varies by Risk of Heart Failure Hospitalization: Applying the Tufts MC HF Risk Model. |
Q35019683 | Dilemmas in end-stage heart failure |
Q34514036 | Dimensionality and reliability of the self-care of heart failure index scales: further evidence from confirmatory factor analysis. |
Q55421109 | Direct Cardiac Reprogramming: Progress and Promise. |
Q38766202 | Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure |
Q34357452 | Diuretic use in heart failure and outcomes |
Q41385955 | Do anabolic nutritional supplements stimulate human growth hormone secretion in elderly women with heart failure? |
Q35179984 | Does B-type natriuretic peptide-guided therapy improve outcomes in patients with chronic heart failure? A systematic review and meta-analysis of randomized controlled trials |
Q42698007 | Does an intervention designed to improve self-management, social support, and awareness of palliative care address needs of persons with heart failure, family caregivers, and clinicians? |
Q64965703 | Does the heart transplant have a future? |
Q47784475 | Early warning systems for the management of chronic heart failure: a systematic literature review of cost-effectiveness models |
Q55346961 | Echo and heart failure: when do people need an echo, and when do they need natriuretic peptides? |
Q33704000 | Economic burden of hospitalizations of Medicare beneficiaries with heart failure |
Q51738672 | Editorial: Transitional Care Clinics to Reduce 30-day Readmissions in Heart Failure Patients. |
Q60301597 | Effect of early physician follow-up on mortality and subsequent hospital admissions after emergency care for heart failure: a retrospective cohort study |
Q92243191 | Effects of Bariatric Surgery on Cardiovascular Disease: A Concise Update of Recent Advances |
Q33722076 | Effects of Transendocardial Stem Cell Injection on Ventricular Proarrhythmia in Patients with Ischemic Cardiomyopathy: Results from the POSEIDON and TAC-HFT Trials |
Q36968934 | Effects of Vitamin D on Cardiac Function in Patients With Chronic HF: The VINDICATE Study |
Q40388134 | Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in Patients with Acute Decompensated Heart Failure and Loop Diuretic Resistance. |
Q48044954 | Efficacy and safety of saxagliptin compared with acarbose in Chinese patients with type 2 diabetes mellitus uncontrolled on metformin monotherapy: Results of a Phase IV open-label randomized controlled study (the SMART study). |
Q93106869 | Efficacy of Vitamin D on Chronic Heart Failure Among Adults |
Q48504109 | Efficacy of intramyocardial injection of Algisyl-LVR for the treatment of ischemic heart failure in swine. |
Q47658430 | Efficient selective screening for heart failure in elderly men and women from the community: A diagnostic individual participant data meta-analysis |
Q37721784 | Egg Consumption and Incidence of Heart Failure: A Meta-Analysis of Prospective Cohort Studies |
Q38678700 | Electrocardiographic Predictors of Heart Failure With Reduced Versus Preserved Ejection Fraction: The Multi-Ethnic Study of Atherosclerosis |
Q41746137 | Electrocardiographic Versus Echocardiographic Left Ventricular Hypertrophy in Prediction of Congestive Heart Failure in the Elderly. |
Q37391005 | Electronically monitored medication adherence predicts hospitalization in heart failure patients |
Q38694200 | Emerging Therapies for Acute and Chronic Heart Failure: Hope or Hype? |
Q47102600 | Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction |
Q37237663 | Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Heart Failure |
Q36257575 | Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Patients with Heart Failure |
Q36905978 | Epidemiology and aetiology of heart failure |
Q36606191 | Epidemiology and cost of heart failure in children. |
Q37318509 | Epidemiology of Heart Failure in Korea: Present and Future |
Q38580530 | Epidemiology of Right Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction |
Q30234501 | Epidemiology of heart failure with preserved ejection fraction |
Q33563221 | Epidemiology, pathophysiology, and prognosis of heart failure in the elderly |
Q93129318 | Epigenetic therapies in heart failure |
Q88453278 | Epigenetics of Aberrant Cardiac Wound Healing |
Q38408408 | Epigenetics of the failing heart |
Q88489317 | Essential Elements of Early Post Discharge Care of Patients with Heart Failure |
Q38789122 | Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement. |
Q90667730 | Estradiol Treatment Initiated Early After Ovariectomy Regulates Myocardial Gene Expression and Inhibits Diastolic Dysfunction in Female Cynomolgus Monkeys: Potential Roles for Calcium Homeostasis and Extracellular Matrix Remodeling |
Q38905198 | European Society of Cardiology - Acute Cardiovascular Care Association position paper on safe discharge of acute heart failure patients from the emergency department |
Q92658815 | Evaluating risk prediction models for adults with heart failure: A systematic literature review |
Q39651924 | Evaluation of Mortality and Readmissions following Hospitalization with Heart Failure |
Q35778912 | Evaluation of the Methods and Management of Acute Coronary Events (EMMACE)-3: protocol for a longitudinal study |
Q35139977 | Evolution of biomarker guided therapy for heart failure: current concepts and trial evidence. |
Q88586628 | Examining Characteristics of Hospitalizations in Heart Failure Patients: Results from the 2009 All-payer Data |
Q37143327 | Exercise Intolerance In Heart Failure With Preserved Ejection Fraction |
Q64233594 | Exercise Training and Heart Failure: A Review of the Literature |
Q100954812 | Experimental model of congestive heart failure induced by transverse aortic constriction in BALB/c mice |
Q89495782 | Expression of microRNA-214 and galectin-3 in peripheral blood of patients with chronic heart failure and its clinical significance |
Q90157368 | Extending Behavioral Medicine to Heart Failure With Preserved Ejection Fraction |
Q35046698 | Factors associated with variations in hospital expenditures for acute heart failure in the United States |
Q38761727 | Family caregiving for persons with heart failure at the intersection of heart failure and palliative care: a state-of-the-science review. |
Q44605331 | Feasibility of including patients with migration background in a structured heart failure management programme: A prospective case-control study exemplarily on Turkish migrants |
Q33880939 | Fluid overload as a major target in management of cardiorenal syndrome: Implications for the practice of peritoneal dialysis |
Q64938227 | Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan. |
Q59806747 | From bedside to bench and back again: translational studies of mechanical unloading of the left ventricle to promote recovery after acute myocardial infarction |
Q38687232 | Future Prospects for the Total Artificial Heart |
Q33740534 | Future declines of coronary heart disease mortality in England and Wales could counter the burden of population ageing. |
Q54088960 | G protein-coupled estrogen receptor (GPER) deficiency induces cardiac remodeling through oxidative stress. |
Q42359693 | GPER is required for the age-dependent upregulation of the myocardial endothelin system |
Q38400860 | Gastric Bypass Surgery Produces a Durable Reduction in Cardiovascular Disease Risk Factors and Reduces the Long-Term Risks of Congestive Heart Failure |
Q52628857 | Gastrointestinal Hemorrhage in Left Ventricular Assist Device Patients: Red Scare or Pressure from the Right? |
Q38843833 | Gender Differences in the Risk of Adverse Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction |
Q91270618 | Gender differences in Egyptian patients hospitalized with heart failure: insights from the European Society of Cardiology Heart Failure Long-Term Registry |
Q90663940 | Genetics of dilated cardiomyopathy: practical implications for heart failure management |
Q57095663 | Global Public Health Burden of Heart Failure |
Q38254025 | Global perspectives in hospitalized heart failure: regional and ethnic variation in patient characteristics, management, and outcomes |
Q48218551 | Growth Hormone (GH) and Cardiovascular System |
Q89601140 | Guideline-directed medical therapy in elderly patients with heart failure with reduced ejection fraction: a cohort study |
Q90085905 | Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant |
Q36424089 | Health Literacy Mediates the Relationship Between Age and Health Outcomes in Patients With Heart Failure |
Q36079869 | Health Literacy and Heart Failure: A Systematic Review |
Q47348712 | Health Literacy and Outcomes in Patients With Heart Failure: A Prospective Community Study |
Q36141353 | Health literacy and mortality: a cohort study of patients hospitalized for acute heart failure |
Q47922014 | Healthcare Costs Among Patients with Heart Failure: A Comparison of Costs between Matched Decedent and Survivor Cohorts |
Q96026980 | Healthy lifestyle and risk of incident heart failure with preserved and reduced ejection fraction among post-menopausal women: The women's health initiative study |
Q22241921 | Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association |
Q30238784 | Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association |
Q37065389 | Heart Failure Among Older Adults in Skilled Nursing Facilities: More of a Dilemma Than Many Now Realize. |
Q38932260 | Heart Failure Incidence and Mortality in the Southern Community Cohort Study. |
Q92715840 | Heart Failure With Preserved Ejection Fraction and Adipose Tissue: A Story of Two Tales |
Q54963948 | Heart Failure and Frailty in the Community-Living Elderly Population: What the UFO Study Will Tell Us. |
Q39540471 | Heart Failure in Older Adults |
Q91600853 | Heart Failure in Older Adults: A Geriatrician Call for Action |
Q26745543 | Heart Failure: Diagnosis, Management and Utilization |
Q29547691 | Heart disease and stroke statistics--2014 update: a report from the American Heart Association |
Q56210548 | Heart failure |
Q26740285 | Heart failure across Asia: Same healthcare burden but differences in organization of care |
Q93147758 | Heart failure awareness in the Korean general population: Results from the nationwide survey |
Q92292783 | Heart failure drug treatment |
Q93026435 | Heart failure hospitalization reduction and cost savings achieved by improved delivery of effective biventricular pacing: economic implications of the OLE study under the US setting |
Q91755767 | Heart failure in Finland: clinical characteristics, mortality, and healthcare resource use |
Q61454581 | Heart failure mortality compared between elderly and non-elderly Thai patients |
Q92314987 | Heart failure mortality prediction using PRISM score and development of a classification and regression tree model to refer patients for palliative care consultation |
Q38592514 | Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review |
Q35578498 | Heart failure remote monitoring: evidence from the retrospective evaluation of a real-world remote monitoring program |
Q91952587 | Heart failure risk reduction: is fit and overweight or obese better than unfit and normal weight? |
Q38931738 | Heart failure with preserved ejection fraction and skeletal muscle physiology |
Q43925452 | Heart failure, post-hospital mortality and renal function in Tanzania: A prospective cohort study |
Q42199698 | Heart failure: preventing disease and death worldwide |
Q41630624 | Heart rate-induced modifications of concentric left ventricular hypertrophy: exploration of a novel therapeutic concept |
Q38654054 | Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics |
Q92632420 | Heart-Type Fatty Acid-Binding Protein (H-FABP) and its Role as a Biomarker in Heart Failure: What Do We Know So Far? |
Q33916984 | Heterogeneity in national U.S. mortality trends within heart disease subgroups, 2000-2015. |
Q38664709 | High prevalence of subclinical cerebral infarction in patients with heart failure with preserved ejection fraction |
Q41808626 | High risk percutaneous coronary interventions-significance of left ventricular assist device for clinical practice |
Q40350551 | High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis). |
Q52621433 | Home Hospitalization for Acute Decompensated Heart Failure: Opportunities and Strategies for Improved Health Outcomes. |
Q34468845 | Home telehealth uptake and continued use among heart failure and chronic obstructive pulmonary disease patients: a systematic review |
Q64131213 | Hospital-based quality improvement interventions for patients with heart failure: a systematic review |
Q42354873 | How to establish a successful destination therapy ventricular assist device program |
Q92454801 | Hurdles to Cardioprotection in the Critically Ill |
Q35794539 | I Brazilian Registry of Heart Failure - Clinical Aspects, Care Quality and Hospitalization Outcomes |
Q37676652 | Identification and Use of Frailty Indicators from Text to Examine Associations with Clinical Outcomes Among Patients with Heart Failure |
Q36223832 | Identification of Emergency Department Patients With Acute Heart Failure at Low Risk for 30-Day Adverse Events: The STRATIFY Decision Tool |
Q41232264 | If home telemonitoring reduces mortality in heart failure, is this just due to better guideline-based treatment? |
Q38993415 | Imaging the Propagation of the Electromechanical Wave in Heart Failure Patients with Cardiac Resynchronization Therapy |
Q92810672 | Immune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy |
Q39029380 | Immunosuppression and adult heart transplantation: emerging therapies and opportunities. |
Q50083097 | Impact of Body Mass Index on Heart Failure by Race/Ethnicity From Get With The Guidelines-Heart Failure (GWTG-HF) Registry. |
Q88711703 | Impact of Exercise Training on Peak Oxygen Uptake and its Determinants in Heart Failure with Preserved Ejection Fraction |
Q36714012 | Impact of Nitrate Use on Survival in Acute Heart Failure: A Propensity-Matched Analysis |
Q38667041 | Impact of Site Selection and Study Conduct on Outcomes in Global Clinical Trials |
Q93377309 | Impact of a Pharmacist-Led Intervention on 30-Day Readmission and Assessment of Factors Predictive of Readmission in African American Men With Heart Failure |
Q57574191 | Impact of a nurse-led home and clinic-based secondary prevention programme to prevent progressive cardiac dysfunction in high-risk individuals: the Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF) randomized controlled study |
Q91646961 | Impact of leadership development workshops in facilitating team-based practice transformation |
Q36805655 | Impaired skeletal muscle vasodilation during exercise in heart failure with preserved ejection fraction |
Q47863918 | Implant Strategy-Specific Changes in Symptoms in Response to Left Ventricular Assist Devices. |
Q38611533 | Implantable Hemodynamic Monitoring in Ambulatory Heart Failure: Who, When, Why, How? |
Q52360900 | Implantable devices for heart failure monitoring and therapy. |
Q55119320 | Implementation and Evaluation of a Smartphone-Based Telemonitoring Program for Patients With Heart Failure: Mixed-Methods Study Protocol. |
Q99409927 | Improved 30 day heart failure rehospitalization prediction through the addition of device-measured parameters |
Q38936829 | Improved Diastolic Function Is Associated With Higher Cardiac Output in Patients With Heart Failure Irrespective of Left Ventricular Ejection Fraction |
Q46720750 | Improved medical expenditure and survival with integration of traditional Chinese medicine treatment in patients with heart failure: A nationwide population-based cohort study |
Q46810238 | Improving care for patients with acute heart failure: before, during and after hospitalization |
Q49911536 | Incident Heart Failure in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study. |
Q58718917 | Indirect costs and public finance consequences of heart failure in Poland, 2012-2015 |
Q52589298 | Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure. |
Q57461747 | Inhibition of GSK-3 to induce cardiomyocyte proliferation-a recipe for in situ cardiac regeneration |
Q90268226 | Inhibition of Interleukin-6/glycoprotein 130 signalling by Bazedoxifene ameliorates cardiac remodelling in pressure overload mice |
Q52662712 | Innovation in Heart Failure Treatment: Life Expectancy, Disability, and Health Disparities. |
Q38682105 | Inpatient Mortality Risk Scores and Postdischarge Events in Hospitalized Heart Failure Patients: A Community-Based Study |
Q36868379 | Inpatient Utilization and Costs for Medicare Fee-for-Service Beneficiaries with Heart Failure |
Q46539324 | Integrated Omic Analysis of a Guinea Pig Model of Heart Failure and Sudden Cardiac Death. |
Q88151527 | Integrating electronic health records into the study of heart failure: promises and pitfalls |
Q50069569 | Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Dec |
Q45073053 | Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial). |
Q48576464 | Intermittent Aortic Valve Opening and Risk of Thrombosis in Ventricular Assist Device Patients. |
Q37257407 | International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry |
Q89736017 | Intramyocardial Injections to De-Stiffen the Heart: A Subject-Specific in Silico Approach |
Q47617357 | Invasive Validation of the Echocardiographic Assessment of Left Ventricular Filling Pressures Using the 2016 Diastolic Guidelines: Head-to-Head Comparison with the 2009 Guidelines. |
Q26822876 | Iron deficiency in patients with heart failure |
Q50048615 | Is ejection fraction in heart failure a limitation or an opportunity? |
Q36012181 | It is time to stop counting calories, and time instead to promote dietary changes that substantially and rapidly reduce cardiovascular morbidity and mortality |
Q39850479 | Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society |
Q41686228 | Korean Guidelines for Diagnosis and Management of Chronic Heart Failure. |
Q48581549 | LVAD Outflow Graft Angle and Thrombosis Risk. |
Q38886473 | Large animal model of functional tricuspid regurgitation in pacing induced end-stage heart failure. |
Q35353844 | Late systolic central hypertension as a predictor of incident heart failure: the Multi-ethnic Study of Atherosclerosis |
Q88711503 | Left Ventricular Assist Devices in the Management of Heart Failure |
Q89584259 | Left Ventricular Diastolic Myocardial Stiffness and End-Diastolic Myofibre Stress in Human Heart Failure Using Personalised Biomechanical Analysis |
Q57288763 | Left ventricular assist device recovery: does duration of mechanical support matter? |
Q90290987 | Left ventricular assist devices as destination therapy in stage D heart failure |
Q40638466 | Left ventricular hypertrophy by ECG versus cardiac MRI as a predictor for heart failure. |
Q46759837 | Less with More: Hospitalization Cost and Event Rates with Quadripolar versus Bipolar CRT-D System |
Q93017682 | Long Noncoding Competing Endogenous RNA Networks in Age-Associated Cardiovascular Diseases |
Q38599662 | Long-term survival following the development of heart failure in an elderly hypertensive population |
Q38974968 | Longer-than-average length of stay in acute heart failure : Determinants and outcomes |
Q55077284 | Low cardiorespiratory fitness is associated with higher extracellular vesicle counts in obese adults. |
Q64085796 | Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin-Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure |
Q41968841 | Lung Edema Clearance: Relevance to Patients with Lung Injury |
Q94595715 | Macrophage Activities in Myocardial Infarction and Heart Failure |
Q38537053 | Management of Noncardiac Comorbidities in Chronic Heart Failure |
Q86767777 | Management of heart failure patients through integrative medical group visits |
Q38402807 | Managing comorbidities in patients with chronic heart failure: first, do no harm |
Q45063526 | Measures of Ventricular-Arterial Coupling and Incident Heart Failure With Preserved Ejection Fraction: A Matched Case-Control Analysis |
Q89431912 | Mechanisms, diagnosis, and treatment of heart failure with preserved ejection fraction and diastolic dysfunction |
Q40784558 | Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients. |
Q37076034 | Medication Adherence Interventions Improve Heart Failure Mortality and Readmission Rates: Systematic Review and Meta-Analysis of Controlled Trials |
Q38738357 | Medication Adherence Mediates the Relationship Between Heart Failure Symptoms and Cardiac Event-Free Survival in Patients With Heart Failure |
Q38351179 | Medication adherence interventions for heart failure patients: A meta-analysis. |
Q38532867 | Medication management for left ventricular assist device thrombosis |
Q41808958 | Medication regimen complexity in ambulatory older adults with heart failure |
Q53540692 | Mediterranean diet and risk of heart failure: results from the PREDIMED randomized controlled trial. |
Q42617697 | Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario? |
Q90233412 | Metabolic and Vascular Effect of the Mediterranean Diet |
Q51734232 | MiR-124 aggravates failing hearts by suppressing CD151-facilitated angiogenesis in heart. |
Q26750638 | MicroRNA and Heart Failure |
Q92832083 | Mid-regional pro-atrial natriuretic peptide for the early detection of non-acute heart failure |
Q92530222 | Mineralocorticoid receptor antagonist use after hospitalization of patients with heart failure and post-discharge outcomes: a single-center retrospective cohort study |
Q36877638 | Mitochondrial Reactive Oxygen Species Mediate Cardiac Structural, Functional, and Mitochondrial Consequences of Diet-Induced Metabolic Heart Disease |
Q38246367 | Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart |
Q92302079 | Modeling heart failure in animal models for novel drug discovery and development |
Q30754539 | Mortality Among Patients Hospitalized With Heart Failure and Diabetes Mellitus: Results From the National Inpatient Sample 2000 to 2010. |
Q58543913 | Moving into the next era of PET myocardial perfusion imaging: introduction of novel F-labeled tracers |
Q37245084 | Moving toward comprehensive acute heart failure risk assessment in the emergency department: the importance of self-care and shared decision making |
Q34559891 | Multidisciplinary group clinic appointments: the Self-Management and Care of Heart Failure (SMAC-HF) trial |
Q49203906 | Murine Models of Heart Failure with Preserved Ejection Fraction: a "Fishing Expedition". |
Q64051962 | Myocardial reconstruction in ischaemic cardiomyopathy |
Q93186972 | Myocardial relaxation in human heart failure: Why sarcomere kinetics should be center-stage |
Q41840019 | NIAMI: Towards the optimization of results in primary PCI. |
Q64134434 | National Burden of Heart Failure Events in the United States, 2006 to 2014 |
Q46580571 | National Differences in Trends for Heart Failure Hospitalizations by Sex and Race/Ethnicity |
Q47395561 | National Trends in Admission and In-Hospital Mortality of Patients With Heart Failure in the United States (2001-2014). |
Q50905395 | Natriuretic Peptides in Older Patients With Heart Failure: A Look Into the Seeds of Time. |
Q38780567 | Neprilysin inhibition with sacubitril/valsartan in the treatment of heart failure: mortality bang for your buck |
Q98159528 | Neuromodulation Therapy in Heart Failure: Combined Use of Drugs and Devices |
Q92960219 | New Mechanistic Insight and Approaches for the Field of Acute Mechanical Circulatory Support |
Q39218629 | New developments in the pharmacotherapeutic management of heart failure in elderly patients: concerns and considerations |
Q90057613 | New insights provided by myofibril mechanics in inherited cardiomyopathies |
Q37722194 | New pharmacological and technological management strategies in heart failure |
Q92485555 | Non-invasive Measurement of Dynamic Myocardial Stiffness Using Acoustic Radiation Force Impulse Imaging |
Q35217259 | Non-invasive technology that improves cardiac function after experimental myocardial infarction: Whole Body Periodic Acceleration (pGz). |
Q62610258 | Noninvasive Blood Pressure Monitor Designed for Patients With Heart Failure Supported with Continuous-Flow Left Ventricular Assist Devices |
Q28075185 | Noninvasive Positive Pressure Ventilation in Chronic Heart Failure |
Q50089990 | Normal findings on noninvasive cardiac assessment and the prediction of heart failure: The Multi-Ethnic Study of Atherosclerosis (MESA). |
Q26741100 | Novel role of phosphodiesterase inhibitors in the management of end-stage heart failure |
Q58083516 | Nuanxin capsule for heart failure: A systematic review of randomized controlled trials |
Q92682304 | Nuclear receptor subfamily 4 group A member 2 inhibits activation of ERK signaling and cell growth in response to β-adrenergic stimulation in adult rat cardiomyocytes |
Q35732491 | Nurse-Led Multidisciplinary Heart Failure Group Clinic Appointments: Methods, Materials, and Outcomes Used in the Clinical Trial |
Q28085537 | Nutritional Interventions in Heart Failure: A Systematic Review of the Literature |
Q49546408 | Observation Versus Inpatient Stay for Heart Failure: Is It Semantics? |
Q90143267 | Opportunities and Challenges of Claims-Based Quality Assessment: The Case of Postdischarge β-Blocker Treatment in Patients With Heart Failure With Reduced Ejection Fraction |
Q37670957 | Optimal timing of same-admission orthotopic heart transplantation after left ventricular assist device implantation |
Q39142609 | Outcomes in acute heart failure: 30-day readmission versus death |
Q90153276 | Outcomes of a Transitional Care Clinic to Reduce Heart Failure Readmissions at an Urban Academic Medical Center |
Q90095054 | Outcomes of gastrointestinal bleeding in patients with left ventricular assist devices: a tertiary care experience |
Q39027287 | Palliative Care Interventions for Patients with Heart Failure: A Systematic Review and Meta-Analysis |
Q47549990 | Palliative Care in Heart Failure: Rationale, Evidence, and Future Priorities |
Q37328775 | Parathyroid hormone and risk of heart failure in the general population: A meta-analysis of prospective studies |
Q30823346 | Partial LVAD restores ventricular outputs and normalizes LV but not RV stress distributions in the acutely failing heart in silico. |
Q38718829 | Pathophysiological mechanism and therapeutic role of S100 proteins in cardiac failure: a systematic review. |
Q48095229 | Pathophysiology of acute heart failure syndrome: a knowledge gap. |
Q38725363 | Patient Perceptions on Facilitating Follow-Up After Heart Failure Hospitalization. |
Q39681115 | Patient engagement with a mobile web-based telemonitoring system for heart failure self-management: a pilot study. |
Q90393579 | Patients report more severe daily limitations than recognized by their physicians |
Q37693957 | Patients with heart failure as co-designers of an educational website: implications for medical education. |
Q34115818 | Patients' annual income adequacy, insurance premiums and out-of-pocket expenses related to heart failure care. |
Q36654892 | Patients' decision making process and expectations of a left ventricular assist device pre and post implantation |
Q35028584 | Pediatric heart failure: current state and future possibilities |
Q55411189 | Perceived Social Isolation and Outcomes in Patients With Heart Failure. |
Q39264105 | Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction |
Q35588902 | Perspectives from mechanical circulatory support coordinators on the pre-implantation decision process for destination therapy left ventricular assist devices |
Q90449914 | Pharmacological and Non-pharmacological Strategies for Volume Overload in Acute Decompensated Congestive Heart Failure: A Review Article |
Q47614022 | Pharmacotherapy Choice Is Associated with 2-Year Mortality for Patients with Heart Failure and Reduced Ejection Fraction |
Q40027666 | Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center. |
Q91988023 | Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure |
Q90666819 | Physical Function, Frailty, Cognition, Depression, and Quality of Life in Hospitalized Adults ≥60 Years With Acute Decompensated Heart Failure With Preserved Versus Reduced Ejection Fraction |
Q40311889 | Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure |
Q30730318 | Post-discharge Follow-up Characteristics Associated With 30-Day Readmission After Heart Failure Hospitalization |
Q38847918 | Potential beneficial effects of sacubitril-valsartan in renal disease: a new field for a new drug |
Q30251531 | Potential new drug treatments for congestive heart failure |
Q38908723 | Practical approach on frail older patients attended for acute heart failure |
Q90111024 | Precipitating Factors for Hospitalization with Heart Failure: Prevalence and Clinical Impact Observations from the Gulf CARE (Gulf aCute heArt failuRe rEgistry) |
Q36992652 | Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes |
Q91071243 | Predicting adults likely to develop heart failure using readily available clinical information: An analysis of heart failure incidence using the NHEFS |
Q92425904 | Prediction of Left Ventricular Mechanics Using Machine Learning |
Q91105604 | Prediction of incident heart failure by serum amino-terminal pro-B-type natriuretic peptide level in a community-based cohort |
Q35855340 | Predictors of medication nonadherence differ among black and white patients with heart failure |
Q47738696 | Preload-corrected dynamic Starling mechanism in patients with heart failure with preserved ejection fraction. |
Q48524715 | Presence of micro- and macroalbuminuria and the association with cardiac mechanics in patients with type 2 diabetes. |
Q40066805 | Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality |
Q39172352 | Primary palliative care for heart failure: what is it? How do we implement it? |
Q92628957 | Problems Experienced in the First Month After Discharge From a Heart Failure-Related Hospitalization |
Q61797746 | Proceedings of the 3rd annual Acute Cardiac Unloading and REcovery (A-CURE) symposium |
Q47797992 | Production of Single Contracting Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Matrigel Mattress Technique. |
Q30241494 | Productivity losses associated with cardiovascular disease: a systematic review |
Q90219822 | Prognostic Impact of Chronic Kidney Disease in Patients with Heart Failure |
Q36309695 | Prognostic Impact of In-Hospital and Postdischarge Heart Failure in Patients With Acute Myocardial Infarction: A Nationwide Analysis Using Data From the Cardiovascular Disease in Norway (CVDNOR) Project |
Q40272769 | Prognostic value of long-term blood pressure changes in patients with chronic heart failure |
Q40052538 | Prospective Association of Physical Activity and Heart Failure Hospitalizations Among Black Adults With Normal Ejection Fraction: The Jackson Heart Study. |
Q39195639 | Protective Actions of H2S in Acute Myocardial Infarction and Heart Failure |
Q39432092 | Protein kinase C and cardiac dysfunction: a review |
Q38268959 | Proteomics of the periconception milieu |
Q89712807 | Pseudouridine and N-formylmethionine associate with left ventricular mass index: Metabolome-wide association analysis of cardiac remodeling |
Q40490176 | Psychiatric conditions as predictors of rehospitalization among African American patients hospitalized with heart failure |
Q55119532 | Psychometric Analysis of the Heart Failure Somatic Perception Scale as a Measure of Patient Symptom Perception. |
Q87939322 | Pulmonary Congestion by Lung Ultrasound in Ambulatory Patients With Heart Failure With Reduced or Preserved Ejection Fraction and Hypertension |
Q30851193 | Pulmonary artery pressure-guided heart failure management: US cost-effectiveness analyses using the results of the CHAMPION clinical trial |
Q89450884 | Race and Sex Differences in Modifiable Risk Factors and Incident Heart Failure |
Q38787755 | Race/Ethnic Differences in Outcomes Among Hospitalized Medicare Patients With Heart Failure and Preserved Ejection Fraction |
Q39617982 | Racial and Ethnic Differences in Heart Failure Readmissions and Mortality in a Large Municipal Healthcare System. |
Q47250954 | Racial and Ethnic Differences in Trajectories of Hospitalization in US Men and Women With Heart Failure |
Q36085697 | Racial differences in clinical treatment and self-care behaviors of adults with chronic heart failure |
Q91860801 | Rapamycin persistently improves cardiac function in aged, male and female mice, even following cessation of treatment |
Q49848555 | Rationale and design of TRANSITION: a randomized trial of pre-discharge vs. post-discharge initiation of sacubitril/valsartan. |
Q39626663 | Rationale and design of the PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study) Stockholm heart failure study: an epidemiological regional study in Stockholm county of 2.1 million inhabitants |
Q38261513 | Rationale and therapeutic opportunities for natriuretic peptide system augmentation in heart failure |
Q39410727 | Rationales and choices for the treatment of patients with NYHA class II heart failure |
Q36098094 | Reactive hyperemia is associated with adverse clinical outcomes in heart failure |
Q35849384 | Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure |
Q36290215 | Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients. |
Q46335976 | Recent advances in point-of-care testing for natriuretic peptides: potential impact on heart failure diagnosis and management |
Q99565745 | Redox signaling and Alzheimer's disease: from pathomechanism insights to biomarker discovery and therapy strategy |
Q37011796 | Reducing Disparities in Cardiovascular Health: Social Determinants Matter |
Q38192824 | Regenerative implants for cardiovascular tissue engineering |
Q37710165 | Registry-Based Pragmatic Trials in Heart Failure: Current Experience and Future Directions |
Q48369499 | Regulation of circulating chromogranin B levels in heart failure. |
Q50355346 | Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial: Design and rationale. |
Q63811744 | Relation Between Cigarette Smoking and Heart Failure (from the Multiethnic Study of Atherosclerosis) |
Q93157384 | Relation of Living in a "Food Desert" to Recurrent Hospitalizations in Patients With Heart Failure |
Q97567792 | Relationship between the place of living and mortality in patients with advanced heart failure |
Q58790933 | Relationship of Electromechanical Dyssynchrony in Patients Submitted to CRT With LV Lead Implantation Guided by Gated Myocardial Perfusion Spect |
Q41069120 | Relationship of Office and Ambulatory Blood Pressure With Left Ventricular Global Longitudinal Strain |
Q58705696 | Relationship of Transmural Variations in Myofiber Contractility to Left Ventricular Ejection Fraction: Implications for Modeling Heart Failure Phenotype With Preserved Ejection Fraction |
Q38744470 | Remote Monitoring in Heart Failure: the Current State |
Q38953625 | Remote Monitoring to Reduce Heart Failure Readmissions |
Q39383368 | Remote haemodynamic-guided care for patients with chronic heart failure: a meta-analysis of completed trials |
Q55484690 | Resource Utilization in Pediatric Patients Supported With Ventricular Assist Devices in the United States: A Multicenter Study From the Pediatric Interagency Registry for Mechanically Assisted Circulatory Support and the Pediatric Health Information |
Q64245682 | Responsiveness and minimal clinically important difference of the Minnesota living with heart failure questionnaire |
Q59792533 | Risk Stratification of Sudden Cardiac Death in Patients with Heart Failure: An update |
Q57054183 | Role of Percutaneous Chronic Total Occlusion Interventions in Patients with Ischemic Cardiomyopathy and Reduced Left Ventricular Ejection Fraction |
Q39458524 | Role of Speckle Tracking Echocardiography in Dilated Cardiomyopathy: A Review |
Q39148915 | Role of the Pharmacist for Improving Self-care and Outcomes in Heart Failure |
Q90676214 | SGLT-2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects |
Q95570983 | SGLT-2 inhibitors for people with type 2 diabetes |
Q41810657 | STOP-HF: Expanding the role of HF programs into the community |
Q90583568 | Sacubitril/Valsartan (LCZ696): A Novel Treatment for Heart Failure and its Estimated Cost Effectiveness, Budget Impact, and Disease Burden Reduction in Germany |
Q62491883 | Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram |
Q48033305 | Seasonal variation in hospitalization outcomes in patients admitted for heart failure in the United States. |
Q45862456 | Selective Pressure-Regulated Retroinfusion for Gene Therapy Application in Ischemic Heart Disease |
Q58610626 | Self-Care Interventions for Adults with Heart Failure: A Systematic Review and Meta-analysis Protocol |
Q91616835 | Self-management of heart failure in dementia and cognitive impairment: a systematic review |
Q38798476 | Serelaxin for the treatment of heart failure |
Q33845755 | Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study |
Q33970136 | Serelaxin: a novel therapy for acute heart failure with a range of hemodynamic and non-hemodynamic actions |
Q89535686 | Serial Biomarkers of De Novo Lipogenesis Fatty Acids and Incident Heart Failure in Older Adults: The Cardiovascular Health Study |
Q36248209 | Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization. |
Q38635685 | Sex-specific temporal trends in the incidence and prevalence of hospitalized patients with preserved versus reduced left ventricular ejection fraction heart failure: A Japanese community-wide study |
Q55088794 | Shexiang Baoxin Pills as an Adjuvant Treatment for Chronic Heart Failure: A System Review and Meta-Analysis. |
Q38863043 | Skilled Nursing Facility Use and Hospitalizations in Heart Failure: A Community Linkage Study |
Q38636431 | Sleep disordered breathing in older adults with heart failure with preserved ejection fraction |
Q38546917 | Small molecule and peptide therapies for chronic heart failure: a patent review (2011 - 2014). |
Q37708944 | Soluble tumor necrosis factor receptors and heart failure risk in older adults: Health, Aging, and Body Composition (Health ABC) Study |
Q28070064 | Spotlight on valsartan-sacubitril fixed-dose combination for heart failure: the evidence to date |
Q88673406 | Stable but Progressive Nature of Heart Failure: Considerations for Primary Care Physicians |
Q35690546 | Stage A Heart Failure Is Not Adequately Recognized in US Adults: Analysis of the National Health and Nutrition Examination Surveys, 2007-2010 |
Q98466834 | Statistics of heart failure and mechanical circulatory support in 2020 |
Q47872194 | Strategies for supporting intervention fidelity in the rehabilitation therapy in older acute heart failure patients (REHAB-HF) trial |
Q35335685 | Stratifying patients at the risk of heart failure hospitalization using existing device diagnostic thresholds |
Q88298129 | Stress, cognitive appraisal, coping, and event free survival in patients with heart failure |
Q24186286 | Structured telephone support or non-invasive telemonitoring for patients with heart failure |
Q58732357 | Study protocol for a cohort study of patients with advanced heart failure in Singapore |
Q92303973 | Study protocol of coaching end-of-life palliative care for advanced heart failure patients and their family caregivers in rural appalachia: a randomized controlled trial |
Q64927166 | Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution. |
Q99629087 | Substrate metabolism regulated by Sestrin2-mTORC1 alleviates pressure overload-induced cardiac hypertrophy in aged heart |
Q89235554 | Substrates and potential therapeutics of ventricular arrhythmias in heart failure |
Q47215949 | Suppression of Activated FOXO Transcription Factors in the Heart Prolongs Survival in a Mouse Model of Laminopathies |
Q38945834 | Symptom burden in heart failure: assessment, impact on outcomes, and management. |
Q91996002 | Taking a Day Off in the Care of Patients With Acute Decompensated Heart Failure: The Weekend Effect |
Q52685524 | Taking cardiology clinical trials to the next level: A call to action. |
Q37425473 | Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial |
Q38223913 | Telemonitoring in heart failure: Big Brother watching over you. |
Q37619070 | Temporal Trends of Hospitalized Patients with Heart Failure in Korea |
Q94554274 | Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis |
Q57818797 | The American Heart Association Heart Failure Summit, Bethesda, April 12, 2017 |
Q56744993 | The CardioMEMS system in the clinical management of end-stage heart failure patients: three case reports |
Q55265979 | The Cost of Hyperkalemia in the United States. |
Q52684873 | The Current Focus of Heart Failure Clinical Trials. |
Q47787428 | The Development and Acceptability of a Mobile Application for Tracking Symptoms of Heart Failure Among Older Adults |
Q36422577 | The Frank-Starling mechanism involves deceleration of cross-bridge kinetics and is preserved in failing human right ventricular myocardium |
Q89990345 | The Heart Failure Association Atlas: rationale, objectives, and methods |
Q52715902 | The Impact of Pazopanib on the Cardiovascular System. |
Q28067832 | The Role of Cardiac Side Population Cells in Cardiac Regeneration |
Q36079293 | The Role of Hypertension in Race-Ethnic Disparities in Cardiovascular Disease |
Q88711740 | The Role of Ivabradine and Trimetazidine in the New ESC HF Guidelines |
Q52679961 | The State of the Science on Integrating Palliative Care in Heart Failure. |
Q38798221 | The Third Time's a Charm: Psychometric Testing and Update of the Atlanta Heart Failure Knowledge Test |
Q38558614 | The Three-Decade Long Journey in Heart Failure Drug Development |
Q30240091 | The association of serum magnesium and mortality outcomes in heart failure patients: A systematic review and meta-analysis |
Q90329480 | The burden of heart failure in the general population: a clearer and more concerning picture |
Q26766151 | The cardiac enigma: current conundrums in heart failure research |
Q98170060 | The conventional isoproterenol-induced heart failure model does not consistently mimic the diaphragmatic dysfunction observed in patients |
Q60302039 | The cost impact to Medicare of shifting treatment of worsening heart failure from inpatient to outpatient management settings |
Q37306238 | The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysis |
Q92271500 | The economic burden of heart failure in Denmark from 1998 to 2016 |
Q58804792 | The economic case for US hospitals to revise their approach to heart failure readmission reduction |
Q38611592 | The economic impact of patients with heart failure on the Lebanese healthcare system. |
Q51731338 | The effect of nurse-led group discussions by race on depressive symptoms in patients with heart failure. |
Q42340578 | The evolution of left ventricular assist devices-a moment to reflect |
Q58115629 | The expanding role of implantable devices to monitor heart failure and pulmonary hypertension |
Q38343935 | The genetic landscape of cardiomyopathy and its role in heart failure. |
Q55078568 | The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions. |
Q38654636 | The impact of medication nonadherence on the relationship between mortality risk and depression in heart failure |
Q47791214 | The ixCELL-DCM Trial: Rationale and Design |
Q43153470 | The life cycle of the heart failure patient |
Q59335403 | The metabolic model of heart failure: the role of sodium glucose co-transporter-2 (SGLT-2) inhibition |
Q38742939 | The oxoglutarate receptor 1 (OXGR1) modulates pressure overload-induced cardiac hypertrophy in mice. |
Q38222648 | The pathophysiology of heart failure with preserved ejection fraction. |
Q47192599 | The prognostic significance of improvement in exercise capacity in heart failure patients who participate in cardiac rehabilitation programme |
Q26795502 | The renal nerves in chronic heart failure: efferent and afferent mechanisms |
Q49488565 | Therapeutic Targets for the Multi-system Pathophysiology of Heart Failure: Exercise Training. |
Q89483519 | Therapeutic options in advanced heart failure |
Q104137178 | Time-sensitive approach in the management of acute heart failure |
Q64012586 | Tissue repair and regeneration with endogenous stem cells |
Q36144376 | Tracking clinical status for heart failure patients using ballistocardiography and electrocardiography signal features |
Q38799792 | Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network). |
Q64092741 | Transcriptomics of cardiac biopsies reveals differences in patients with or without diagnostic parameters for heart failure with preserved ejection fraction |
Q36101517 | Transition Networks in a Cohort of Patients with Congestive Heart Failure: A Novel Application of Informatics Methods to Inform Care Coordination. |
Q47155338 | Trauma Resuscitation in a Left Ventricular Assist Device Patient: An Emergency Medicine Simulation Scenario |
Q38821193 | Treatment Considerations and the Role of the Clinical Pharmacist Throughout Transitions of Care for Patients With Acute Heart Failure |
Q38145265 | Treatment of acute heart failure in the emergency department |
Q51412130 | Trends in Hospitalizations and Survival of Acute Decompensated Heart Failure in Four US Communities (2005-2014): The Atherosclerosis Risk in Communities (ARIC) Study Community Surveillance. |
Q64111459 | Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United States |
Q38813931 | Trends in health care expenditure among US adults with heart failure: The Medical Expenditure Panel Survey 2002-2011. |
Q92521896 | Trends in the Use of Cardiac Imaging for Patients With Heart Failure in Canada |
Q38823420 | Trends in the risk of early and late-onset heart failure as an adverse outcome of acute myocardial infarction: A Cardiovascular Disease in Norway project |
Q34695096 | Trial of a family-based education program for heart failure patients in rural Thailand |
Q38802222 | Turning Failure into Success: Trials of the Heart Failure Clinical Research Network |
Q90678493 | US trends in premature heart disease mortality over the past 50 years: Where do we go from here? |
Q41875333 | Ultra-Sensitive NT-proBNP Quantification for Early Detection of Risk Factors Leading to Heart Failure. |
Q38795329 | Ultrafiltration Therapy for Heart Failure: Balancing Likely Benefits against Possible Risks |
Q26996486 | Understanding the epidemic of heart failure: past, present, and future |
Q38732367 | Unlocking the box: basic requirements for an ideal ventricular assist device controller |
Q49892870 | Updates on Device-Based Therapies for Patients with Heart Failure. |
Q38833346 | Use of Tumor Necrosis Factor Alpha Inhibitors for Inflammatory Bowel Disease Patients with Concurrent Heart Failure |
Q94503116 | Utilization of Ultrasound to Assess Volume Status in Heart Failure |
Q89591952 | Validating patient prioritization in the 2018 Revised United Network for Organ Sharing Heart Allocation System: A single-center experience |
Q92158706 | Validity and Reliability Evaluation of the Persian Version of the Heart Failure-Specific Health Literacy Scale |
Q64271605 | Ventricular Assist Devices: an Evolving Field |
Q58759402 | Vital Signs: State-Level Variation in Nonfatal and Fatal Cardiovascular Events Targeted for Prevention by Million Hearts 2022 |
Q47169224 | Vitamin D3 repletion versus placebo as adjunctive treatment of heart failure patient quality of life and hormonal indices: a randomized, double-blind, placebo-controlled trial. |
Q100490880 | Waist-to-height ratio and skipping breakfast are predictive factors for high blood pressure in adolescents |
Q38950580 | What is the cost of non-response to cardiac resynchronization therapy? Hospitalizations and healthcare utilization in the CRT-D population |
Q38116756 | What is the optimal place for heart failure treatment and care: home or hospital? |
Q33944629 | What puts heart failure patients at risk for poor medication adherence? |
Q58795766 | Whey protein supplementation for the preservation of mass and muscular strength of patients with heart failure: study protocol for a randomized controlled trial |
Q64902607 | Zhenwu decoction for chronic heart failure: Protocol for a systematic review and meta-analysis. |
Q52678651 | [Efficacy of a multidisciplinary care management program for patients admitted at hospital because of heart failure (ProMIC)]. |
Search more.